250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical Device VC (Venture Capital) Funds in Germany in September 2025

A list of 50 VC (Venture Capital) funds that invest in Medical device startups based in Germany. We rank investors based on the number of investments they made in Medical device companies from Germany. We update this investor list every month.

Top 50 Medical Device VC (Venture Capital) Funds in Germany in September 2025

Investor Medical Device Germany investments
HTGF (High-Tech Gruenderfonds) 20
Bayern Kapital 10
NRW.BANK 7
KfW 7
TGFS - Technologiegründerfonds Sachsen 6
bm-t beteiligungsmanagement thuringen 5
Brandenburg Kapital 5
MIG Capital 5
S-Venture Capital Dortmund 3
Born2Grow 3
Sparrow Ventures 3
Expon Capital 3
bmp Ventures 3
IFB Innovationsstarter 3
Heal Capital 3
SOSV 3
Hevella Capital 3
Playground Global 3
11k Ventures 3
Sofinnova Partners 3
Think.Health 3
M-Invest 2
TechVision Fund 2
Lauder Partners 2
Sparkasse Jena 2
Atlantic Labs 2
YZR Capital 2
Carma Fund 2
Seed Fonds Aachen 2
BayBG Venture Capital 2
Green Park & Golf Ventures 2
Winning Mindset Ventures 2
HealthCap 2
TruVenturo 2
b2venture 2
Entrée Capital 2
AQAL Integral Investing 2
Boehringer Ingelheim Venture Fund 2
Bertelsmann Investments 2
ES KAPITAL 2
DocCheck Guano AG 2
APEX Ventures 2
Wellington Partners 2
Asabys Partners 2
APEX Ventures 2
MassMutual Ventures 2
The TQ Group 2
American RENOLIT Corporation 2
Grönemeyer Health 1
Norgine Ventures 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
HTGF (High-Tech Gruenderfonds) VC Fund · Bonn, Nordrhein-Westfalen, Germany · 45 investments in the past 12 months
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Series A, Funding Round
  • Germany, Switzerland, United States
Portfolio highlights
  • Mevaldi — Mevaldi is a biotechnology company. They investigate, select, and bring to market new technologies in the field of bio-based chemicals. They provide a revolutionary approach that integrates the large-scale biological conversion of sugars to low-cost mevalonolactone with a further cascade of thermo-catalytic conversions to various bio-monomers.
  • TrustNXT — TrustNXT is the trust authority for digital media, providing innovative software solutions to safeguard digital photos and videos from manipulation. Our technology verifies the origin, content, and metadata of digital media, while advanced forensic tools empower users to assess the trustworthiness of visual content. With a mission to protectauthenticity and foster safer digital environments, TrustNXT is committed to combating fraud and ensuring the integrity of digital media in today's digital world.
  • Pactos — Pactos streamlines and digitizes processes to enable large and medium-sized businesses to effectively and centrally procure and manage their contingent labor.
Bayern Kapital VC Fund · Landshut, Bayern, Germany · 26 investments in the past 12 months
Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Series A, Funding Round
  • Germany, United States, Finland
Portfolio highlights
  • abaut — abaut is a SaaS provider for the construction and mining industry. The company’s goal is the digital replication of construction and mining progress and processes by combining a multitude of data sources, which are processed with the help of AI. Their software enables site managers to make better decisions, by providing site managers a holisticview over his site. Therefore, the risk of inefficiencies, process bottlenecks and cost & schedule overruns is reduced. The company was founded in 2017 and is headquartered in Munich, Germany.
  • Filics — A scalable transport solution for standardized load carriers with a minimum energy footprint
  • Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
NRW.BANK VC Fund · Düsseldorf, Nordrhein-Westfalen, Germany · 8 investments in the past 12 months
NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks.
Show more
Investment focus
  • Software, Information Technology, Biotechnology
  • Seed, Series A, Series B
  • Germany, United States, France
Portfolio highlights
  • Lidrotec — Lidrotec aim to expand the application potential of processing with ultra-short pulse lasers.
  • DEFENDERBOX — DefenderBox - your protection against electrosmog. Innovative shielding technology for home and office. Test now for 4 weeks free of charge and reduce electrosmog sustainably.
  • Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
KfW VC Fund · Frankfurt, Hessen, Germany
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Funding Round, Series A, Series B
  • Germany, India, Kenya
Portfolio highlights
  • Vectoflow — Vectoflow is an innovative company developing fluid-dynamic metrology devices for fluid flow and dynamics measurement. It offers standardized and customized flow measurement technology that measures the static and total pressure, velocity, and angle of attack of a flow. These products are used in motorsport, aviation, turbine machine development,and research sectors.
  • Electrochaea — Electrochaea is commercializing a disruptive, scalable technology to convert electric power into methane, the principal component of natural gas. Using CO2 as a feedstock gas, power can be efficiently converted to renewable natural gas for power storage, for transportation fuels, or for transmission via a natural gas network. The company licensedtechnology from the University of Chicago and is led by the Nidus Partners, a St. Louis investment group specializing in renewable energy. Mich Hein, a Nidus Managing Partner, serves as CEO.Electrochaea has developed a commercially viable and disruptive solution for utility-scale energy storage, grid balancing, and carbon reuse. Their proprietary process converts low-cost and stranded electricity and carbon dioxide into pipeline-grade renewable gas for direct injection into the existing natural gas grid, a conversion process known as “power-to-gas”.
  • CryoTherapeutics — USING CRYOTHERAPY TO TREAT AND PREVENT HEART ATTACKS
TGFS - Technologiegründerfonds Sachsen VC Fund · Leipzig, Sachsen, Germany · 6 investments in the past 12 months
TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Series A, Funding Round
  • Germany, United States
Portfolio highlights
  • CYNiO — CYNiO is an innovative chemical startup dedicated to revolutionizing the production of isocyanates through a safe, flexible, and sustainable approach.
  • Zepta — Zepta emphasizes "digital solutions and sustainability in pest control." Zepta develops a digital approach for protecting humans from pests.
  • LipoCheck — LipoCheck is a healthtech startup that focuses on improving the diagnosis and treatment of lipedema, a condition that affects millions of women. The company offers a digital platform that serves as a support system for patients and treating physicians. LipoCheck's services include helping patients recognize lipedema and providing assistance inbecoming symptom-free. The platform was developed with the experiences of practicing doctors, product managers, and software developers. In addition to its digital services, LipoCheck also offers a range of merchandise including hoodies and shirts.
bm-t beteiligungsmanagement thuringen VC Fund · Erfurt, Thuringen, Germany · 5 investments in the past 12 months
bm|t supports innovative and growth-oriented companies in Thuringia with equity investments and venture capital.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Funding Round, Series A
  • Germany, United States
Portfolio highlights
  • Leapter — Leapter is created to revolutionize enterprise software development by turning business needs into practical, visual designs.
  • warmwind — warmwind operates as an AI operating system for visual process automation.
  • PERCEPTEC — PERCEPTEC is an application-oriented think tank with the aim of accelerating the process of modernization and digitalization of the optometric and ophthalmological sector.
Brandenburg Kapital VC Fund · Potsdam, Brandenburg, Germany · 9 investments in the past 12 months
With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Series A, Funding Round
  • Germany, United Kingdom
Portfolio highlights
  • koppla — koppla is a cloud-based planning and communication tool for LEAN construction sites for both general contractors and subcontractors.
  • ThinkSono — ThinkSono is a company at the cutting edge of medicine and technology.
  • ALVA Energie — Alva delivers turnkey solar systems with integrated energy, heating, and e-mobility for buildings
MIG Capital VC Fund · München, Bayern, Germany · 6 investments in the past 12 months
MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Funding Round, Series B
  • Germany, France, Austria
Portfolio highlights
  • AMSilk — AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics.
  • Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
  • ASTRA Therapeutics — Astra - Therapeutics
S-Venture Capital Dortmund VC Fund · Deutsch, Sachsen, Germany
S-Venture Capital Dortmund aims to fund technology companies and is a German regional investment group.
Show more
Investment focus
  • Biotechnology, Guides, Genetics
  • Series B, Funding Round, Series A
  • Germany
Portfolio highlights
  • Innolume — Innolume has invented a novel comb laser light engine for short-reach optical interconnects between and within computers. Economical wavelength-division multiplexing (WDM) is enabled by this class of low-cost, low-power Fabry-Perot lasers. WDM, familiar from telecom, provides an efficient alternative to multiple lasers and underutilized parallelfiber/waveguides, reducing short-reach system cost and power.
  • Protagen — Protagen is a precision medicine specialist that support drug development, facilitate treatment strategies and improve patient management. Protagen is at the forefront of immuno-profiling and the discovery of novel autoantibody signatures for autoimmune disease and immuno-oncology. Protagen’s SeroTag® technology identifies biomarkers that address anumber of challenges currently hindering the successful development and broader application of both cancer immunotherapies and novel treatments for autoimmune diseases.The company is a leader in patient stratification for autoimmune disease, having developed disease-specific NavigAID stratification panels that profile individual patient’s autoimmune condition and immune status. This precision medicine approach allows for the development and implementation of more targeted therapies for diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS) and others.
  • Scienion — SCIENION AG is a life science company well positioned in the markets of ultra-low volume liquid handling systems and microarray technologies. They provide their customers with an integrated product portfolio facilitating and improving multiparallel bioanalytics, high throughput screening and high throughput production of microarrays in the genomicsand proteomics fields – from early research to manufacturing.
Born2Grow VC Fund · Heilbronn, Baden-Wurttemberg, Germany
Born2Grow is a german venture fund focusing on early stage investments. They invest up to 500k€ in innovative business models. They are based in Heilbronn in Baden-Wuerttemberg. Born2Grow focus on investments lies within the MedTech, BioTech, FinTech area as well as some other online industries
Show more
Investment focus
  • Software, Health Care, Medical
  • Seed, Series A, Series B
  • Germany, Finland, United States
Portfolio highlights
  • Semorai — The SEMORAI Engineering AI Suite is your App Store for AI agents for reliable support in demanding mechanical engineering. Connect comprehensive engineering knowledge with your company know-how to accelerate your processes through AI to an unprecedented degree.
  • Doinstruct — Doinstruct offers mobile training solution for frontline workers.
  • traplinked — Digitale Fallensysteme - Endlich wissen, was los ist! Mit den traplinked Sensormodulen JERRY und TOM erhalten Sie in Echtzeit ein digitales Abbild Ihrer Kontrollpunkte.
Sparrow Ventures VC Fund · Zürich, Zurich, Switzerland
We are a Zurich-based Venture Builder and Growth Equity Investor. With our ambitious team of highly customer-focused entrepreneurs, we are committed to putting our expertise to work and strive to make an impact.
Show more
Investment focus
  • Health Care, Medical Device, Real Estate
  • Series A, Seed, Funding Round
  • Switzerland, Finland, Germany
Portfolio highlights
  • properti — "building the world's greatest real estate company"Properti is a modern, young and pioneering PropTech startup founded in November 2019. Through our unique Properti System, which combines the latest technologies, in-depth expertise and world-class marketing, we provide an exclusive service. Our mission is to change the real estateindustry sustainably with the symbiosis of technology and people to build trustworthiness and transparency. Our goal is to offer customers a full service around the housing ecosystem.
  • HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
  • Selma Finance — With Selma you will get an investment plan that fits to your life and goals. Get started in minutes and let your money work for you.
Expon Capital VC Fund · Luxembourg, Luxembourg, Luxembourg · 8 investments in the past 12 months
Global investor in big ideas with the potential for positive impact & exponential growth
Show more
Investment focus
  • Software, E-Commerce, Financial Services
  • Seed, Series A, Series B
  • Luxembourg, France, United States
Portfolio highlights
  • ClimateCamp — Looking for a sustainable way to collaborate with your suppliers on emissions reduction projects? Look no further than our platform - Book a demo for free!
  • Invitrolize — Our human in vitro model allows for the first time the identification and differentiation of respiratory sensitizers and respiratory irritants under air-liquid interphase realistic exposure conditions.
  • Exobiosphere — Exobiosphere is a cutting-edge company operating at the intersection of space exploration and biotechnology.
bmp Ventures VC Fund · Berlin, Berlin, Germany · 5 investments in the past 12 months
bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.
Show more
Investment focus
  • Software, Information Technology, Manufacturing
  • Seed, Funding Round, Series A
  • Germany, United States, Austria
Portfolio highlights
  • CYNiO — CYNiO is an innovative chemical startup dedicated to revolutionizing the production of isocyanates through a safe, flexible, and sustainable approach.
  • NorcSi GmbH — Entwicklung von neuartigen Batterietechnologien
  • byte robotics — Byte Robotics developed a springboard innovative software technology for robot program generation.
IFB Innovationsstarter VC Fund · Hamburg, Hamburg, Germany · 4 investments in the past 12 months
The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.
Show more
Investment focus
  • Software, SaaS, Artificial Intelligence
  • Seed, Funding Round, Grant
  • Germany, United States
Portfolio highlights
  • mo:re GmbH — Mo:re is building the new gold standard for organoid-based drug development by offering a lab platform that industrialises cell culture workflows.
  • 3D Spark — Profitability and Sustainability Aligned using 3D Spark's Platform - Empowering Manufacturing with Insights and Efficiency!
  • DealCircle — DealCircle is a digital M&A solution and partner of hundreds of M&A advisors. We support in identifying buyers and addressing the market. This provides investors access to a comprehensive deal flow of relevant projects.
Heal Capital VC Fund · Berlin, Berlin, Germany · 4 investments in the past 12 months
Heal Capital is a European venture capital fund backing mission-driven founders with capital and HealthTech-specific expertise, accelerating market access.
Show more
Investment focus
  • Health Care, Artificial Intelligence, Machine Learning
  • Seed, Series A, Pre-Seed
  • Germany, United Kingdom, France
Portfolio highlights
  • Apheris — apheris AI was founded by Robin Rohm and Michael Höh with a shared dream to empower companies to run analytics on decentralized datasets. Michael developed software infrastructure for distributed data during his PhD at Forschungszentrum Julich and his time at BCG. Robin has a background in algebraic theories for data linkage and data privacy andhas experienced the complexity of centralizing sensitive personal healthcare data firsthand in one of his previous start-ups. Through their work, they encountered barriers that limit progress within data driven industries: data is often stored in silos and most companies work in closed data ecosystems. Therefore, Apheris strives to connect the world’s data to extract better insights.
  • Heim Health — Heim Health is a healthcare firm using technology to deliver scalable, community-based solutions.
  • Paloma Health — A technology-enabled provider of children's mental health services, starting with autism assessments.
SOSV VC Fund · Princeton, New Jersey, United States · 75 investments in the past 12 months
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Convertible Note, Pre-Seed
  • United States, India, United Kingdom
Portfolio highlights
  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Hevella Capital VC Fund · Hamburg, Hamburg, Germany
Hevella Capital is a principal investment firm.
Show more
Investment focus
  • E-Commerce, FinTech, Software
  • Seed, Funding Round, Series A
  • Germany, Canada, Austria
Portfolio highlights
  • fulfin — Beantragen Sie Ihre Finanzierung jetzt und wachsen Sie mit Fulfin!
  • HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
  • ChargeX — ChargeX provides electric car charging solutions. Tobias Wagner, Michael Masnitza, and Johannes Engeln founded it in 2017, with its headquarters in Munich in Germany.
Playground Global VC Fund · Palo Alto, California, United States · 7 investments in the past 12 months
Playground Global is an early-stage venture capital firm backing technical and scientific founders with deep engineering expertise, a collaborative environment, and a first-hand understanding of the intricacies of deep tech. Established in 2015 and headquartered in Palo Alto, CA, Playground’s mission is to transform ambitious ideas into impactfulbusinesses that benefit humanity and the planet. We invest in areas that span across next gen compute automation, energy transition and engineered biology. Playground has been an early – and frequently first investor – in companies that include PsiQuantum, Relativity Space, Ultima Genomics, MosaicML (acq. by Databricks), d-Matrix, and Strand Therapeutics.
Show more
Investment focus
  • Software, Robotics, Biotechnology
  • Series A, Seed, Series B
  • United States, Canada, France
Portfolio highlights
  • xLight — xLight to commercialize particle accelerator driven Free Electron Lasers (FEL) for critical US economic and national security applications.
  • Aerones — Robotic wind turbine service company offering maintenance, inspection and repairs worldwide. Reduce downtime and improve the efficiency of your wind park
  • Snowcap Compute — Snowcap Compute develops advanced artificial intelligence computing chips that leverage superconducting technology for faster processing and greater energy efficiency.
11k Ventures VC Fund · Hamburg, Hamburg, Germany
We are a business angel collective based in Germany. We help early-stage startups that want to make a difference by preservation and improvement of human health.
Show more
Investment focus
  • Artificial Intelligence, Health Care, Medical Device
  • Seed, Pre-Seed, Convertible Note
  • Germany, United States
Portfolio highlights
  • DeepSpin — DeepSpin is developing a next-gen, AI-powered MRI machine at a fraction of the cost, size and weight of standard systems, allowing to bring MRI to the point-of-care.
  • Mindpeak — Harnessing the power of Artificial Intelligence and machine learning, Mindpeak products can help make pathology diagnosis faster and more accurate.
  • atmio — atmio helps natural gas operations to find, fix and report methane emissions easily.
Sofinnova Partners VC Fund · Paris, Ile-de-France, France · 18 investments in the past 12 months
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • Actithera — Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows.
  • One Biosciences — One Biosciences unlocks routine analysis of tumor heterogeneity through AI-powered single-cell technologies, transforming precision medicine.
  • Galvanize Therapeutics — Galvanize Therapeutics is an energy-based medical device technology that provides therapeutic products and services to deliver healthcare solutions. The company aims to become the global leader in delivering medical technology innovations that drive biological processes to treat a range of diseases, starting with treating chronic bronchitissymptoms, cardiac arrhythmias, and solid tumors.It was formed by Apple Tree Partners in 2022.
Think.Health VC Fund · Fürstenfeldbruck, Bayern, Germany
Think.Health invests as a boutique risk-taker in healthcare ventures. We continuously seek innovations and disruptive business models in digital healthcare, medical technologies and health service providers,
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Seed, Series A, Series B
  • Germany, United States, Switzerland
Portfolio highlights
  • Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
  • Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
  • Sphingotec GmbH — Improving patient outcomes with innovative diagnostics for critical care: Actionable insights in real-time
M-Invest VC Fund · Singen, Thuringen, Germany
M- Invest GmbH, Singen, Germany, represents the holding company for the business shares and stakes held by the Meder family.
Show more
Investment focus
  • Medical Device, Medical, Software
  • Series A
  • Germany
Portfolio highlights
  • CorTec — Reliable products for active implantable device development. We realize your next project with you and offer individual solutions that meet your specific requirements for Medical Devices, especially in neurotechnology.
  • Capical GmbH — Capical is your partner for target-oriented, fast and sophisticated integration of monitoring solutions in your product. We work in the fields of research, development and productive applications for contact-free ECG measurement for more than 10 years. During that time, we have established Capical as the worldwide leader of the capacitive electrodetechnology.​Our offer covers all stages of the development process. With the target to provide innovative and successful products in collaboration with you, we support you from building first prototypes up till serial production. Your benefit is our extensive know-how and experience from projects in various industry sectors.​Capical has been awarded with the Fresenius Inventor Award, the IHK Technology Transfer Award and additional awards for its capability to transfer the capacitive technology in marketable products. It has been the first company worldwide which has medically approved an ECG-device based on capacitive electrodes and we are capable to defend your and our interests against competitors due to own important property rights.​Join us with our target to establish the capacitive ECG measurement in various market segments to improve the quality of life of elderly or ill persons as well as improve safety and comfort in the increasing segment of automated driving.
TechVision Fund VC Fund · Aachen, Nordrhein-Westfalen, Germany · 3 investments in the past 12 months
VF-Funds for innovative and scalable start-ups from the Rhineland Area, Germany
Show more
Investment focus
  • Software, Health Care, Manufacturing
  • Seed, Series A, Pre-Seed
  • Germany, Spain
Portfolio highlights
  • IonKraft — IonKraft can provide better performance at a lower cost while maintaining recyclability, they also promote material reduction and reuse and are commercializing the technology with funding from the German Federal Ministry for Economic Affairs and Energy (BMWi).
  • Eeden — Eeden engages in the manufacture and supply of textiles.
  • Planted Green — Planted Green plants mixed forests to compensate for CO2 emissions.
Lauder Partners VC Fund · Atherton, California, United States
Lauder Partners, LLC is an entity investing in various realms of the technology field. Lauder invest both directly in companies as well as in funds - both venture and others. Since it primarily invests the capital of Gary Lauder and family members, we don't provide much information to the public.
Show more
Investment focus
  • Software, Internet, Health Care
  • Funding Round, Series B, Seed
  • United States, United Kingdom, China
Portfolio highlights
  • Lassen Peak — PUBLIC SAFETY INNOVATION Threat detection for a safer world Once in a great while, the path of advanced technology unexpectedly joins the basic needs of society. Learn More https://www.lassenpeak.com/wp-content/uploads/2023/12/Globe3.m4v Linkedin Envelope
  • OccamzRazor — OccamzRazor combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development. Our analysis pipeline consists of two proprietary technologies, Panoramic AI and RazorBrain. Together, they are designed to extract data from unstructured text sources (publications, patient reported outcomes, etc.)and join them with structured data (genomics, proteomics, phenomics, etc.) to generate stronger drug discovery hypotheses and more valuable insights. Successful applications include data extraction and curation from biomedical text, novel target identification, and drug repurposing/repositioning.
  • NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.
Sparkasse Jena VC Fund · Jena, Thuringen, Germany
Sparkasse Jena is a German savings bank offers a collection of financial products and services to private, retail, and corporate customers.
Show more
Investment focus
  • Medical, Shopping, E-Commerce
  • Seed, Series A, Series C
  • Germany, United States
Portfolio highlights
  • NovaPump — The NovaPump GmbH is a cardiology company based in Jena/Germany devoloping cutting-edge therapeutical solutions in the field of non-invasive and percutaneous circulation support. The so called PERKAT (PERKutane KATheterpumpe) technique will be offered as pLVAD & pRVAD heart pumps for acute left or right heart patients within the nextyears. PERKAT works together with the current IABP technique (intra aortic balloon pump with about 200,000 cases p.a. internationally) and is the only-one catheter-based & self-expanding, pulsatile & ECG-triggered, cost-effective heart pump technique with a high pump performance. PERKAT is not available on the market so far. Articles in leading scientific journals and presentations at the top four international cardiology conferences in the last years show the medical need, the development status and the technological and medical advantages of PERKAT.
  • Dynamic42 — Dy­nam­ic42 provides, customizes innovative 3D mi­cro­phys­i­o­log­i­cal in vit­ro test systems recre­at­ing human organ key functions. It develops and markets novel, three-dimensional, human organ models (scalloped organ-on-chip technology) for pre­clin­i­cal research and developmental, as well as for testing novel pharmaceutical products,chemicals, and food additives. It is specialized in the area of organ-on-chip technology in the integration of the immune system, which plays a significant role in the occurrence of adverse effects of drugs and has been neglected in the industry and in two-dimensional test systems.
  • PERCEPTEC — PERCEPTEC is an application-oriented think tank with the aim of accelerating the process of modernization and digitalization of the optometric and ophthalmological sector.
Atlantic Labs VC Fund · Berlin, Berlin, Germany · 10 investments in the past 12 months
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures.&nbsp;<br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more
Investment focus
  • Software, Health Care, Financial Services
  • Seed, Pre-Seed, Series A
  • Germany, Switzerland, United States
Portfolio highlights
  • Pletor — The platform where marketers and creatives explore and build custom design agents to achieve 100x more. Like Zapier for visual marketing.
  • Omnisent — Omnisent is a technology company focused on transforming the way we understand and interact with the physical world by extracting intelligence from sound. Their core innovation lies in pairing ultra-low power sonic devices with a Large Acoustic Model (LAM) specifically trained on non-speech audio, enabling the conversion of ambient sounds intoreal-time, actionable intelligence
  • Grouphug — Grouphug turns noisy WhatsApp groups into organized, intelligent pages.
YZR Capital VC Fund · Munich, Bayern, Germany · 5 investments in the past 12 months
We back ambitious HealthTech founders solving complex healthcare challenges. We provide capital, deep sector expertise, and hands-on support to build global champions.
Show more
Investment focus
  • Health Care, Artificial Intelligence, Software
  • Seed, Pre-Seed, Series A
  • Germany, Poland, United Kingdom
Portfolio highlights
  • Vetnio — Vetnio is an AI scribe that records conversations between veterinary professionals and pet owners, automatically generating clinical notes for the meetings. It saves veterinary professionals time, allowing them to focus more on their patients.
  • DeepLife — DeepLife uses deep learning on multi-omics data to model cells and efficiently engineer their behavior.DeepLife is a biotech company with a mission to build the next generation of system biology. The company works in a highly collaborative translational manner, to facilitate the transition of discoveries from the laboratory to patients. Thecompany operates through collaboration with academic groups in their respective areas of expertise.
  • Caire — Caire's objective is to bring healthcare into everyday life, including homes and workplaces.
Carma Fund VC Fund · Munich, Bayern, Germany · 2 investments in the past 12 months
Carma Fund is an early-stage investment fund for advancing life science and healthcare technologies.
Show more
Investment focus
  • mHealth, Health Care, Medical Device
  • Pre-Seed
  • Germany
Portfolio highlights
  • Symphera — An all-in-one surgical system that makes minimally-invasive procedures more efficient.
  • Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
  • Akribion Genomics — Specific, versatile, effective RNA-guided cell depletion
Seed Fonds Aachen VC Fund · Aachen, Nordrhein-Westfalen, Germany
Seed Fonds has a strong competence network with national and international investors, business angels & expertes from the industry. They are specialized in the development of comprehensive financing models offering stability and development opportunities on the long term.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Funding Round, Seed, Series A
  • Germany
Portfolio highlights
  • miacosa — miacosa.de is operated by the Endorsed Goods GmbH. miacosa.de is a social shopping concept from Germany based in Cologne. Social Shopping the miacosa way means that members select their personal shopping team of experts and celebrities that present products they love on miacosa.de Miacosa is for members only. The free service starts with productsfrom the fields of Health Style, Home & Living, Kitchen and fashion accessories.
  • Hemovent — ​​​Based in Aachen, Germany, Hemovent is a privately held medical technology company that is developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Hemovent was founded by serial entrepreneur, Christof Lenz and Oliver Marseille, inventors of the company’s proprietary platform. It is the goal of the company to develop aninnovative solution, with precision and craftsmanship, that will aide patients with lung and heart function while allowing them to be mobile.
  • aquila biolabs — aquila biolabs is a German technology company focusing on the development of innovative laboratory devices for the analysis of shake-flask fermentations in biotechnological, chemical and pharmaceutical research and development.
BayBG Venture Capital VC Fund · München, Bayern, Germany
Innovative post-revenue startups with first customers trust us as highly reliable investors. We have been an active player in the venture capital market for over 25 years. Due to our evergreen approach, we offer institutional venture capital without the limitations of the usual fund structure. Predominantly we invest straight equity. Additionally,we can offer venture debt to mature startups close to break-even in order to avoid further dilution for founders. Being a private investment company we act as both lead investor or co-investor. We can also fulfill the private lead investor role for public investors like Bayern Kapital. Together we are increasing YOUR company's value.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Series A, Series B
  • Germany, Italy, United States
Portfolio highlights
  • DcubeD — Accelerate your space exploration through durable and affordable Release Actuators, Solar Arrays, and Deployables from DCUBED.
  • Parkstory — Parkstory offers fully automated parking solutions that are supported by artificial intelligence.
  • StoryBox — StoryBox provides a Software as a Service solution for businesses to create, share and structure video content to make it searchable. With the system, companies can create and organize smartphone-based videos for any application scenario. Using the app, videos can be created and shared by every employee using templates. The app suggests picturesettings and scene lengths automatically and offers an automated creation which includes corporate design. The content can be stored in the DSGVO-compliant StoryBox cloud and can be accessed, filtered and analyzed from anywhere. Customers include Iveco, Erste Group, Evonik, Alten, and KTM.
Green Park & Golf Ventures VC Fund · Dallas, Texas, United States · 2 investments in the past 12 months
Green Park & Golf, built on over 50 years of operational and financial experience, seeks investment opportunities that offer above-market returns for its investors. Led by Clay Heighten, M.D., and Carl Soderstrom, the Firm delivers strategic solutions, financial backing and a reliable network to its portfolio companies. The Dallas-based Firm iscurrently looking for investment opportunities in medical-related start-ups.Dr. Heighten founded MedicalEdge Healthcare Group in 1993, and Mr. Soderstrom started PhyServe Physician Services in 1998 to administer the financial and operational needs of MedicalEdge. Together, the companies managed over 550 providers in five major markets. In 2011, the companies were sold to Texas Health Resources, a $3.8 billion health care system. That’s when Green Park & Golf was born.After earning his MBA at Southern Methodist University, Mr. Garcia joined them full-time in May 2011 to actively pursue new investment opportunities and monitor other investments in their portfolio. He has prior professional experience at FedEx, Bold Ventures, and Lone Star Investment Advisors.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Seed, Series B
  • United States, Israel, Sweden
Portfolio highlights
  • Prolocor — Our goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.
  • Vellum Health — Vellum Health platform provides on-demand IV enablement & treatment optimized for provider organizations, payers, clinicians, and patients.
  • Affineon Health — Affineon is the AI inbox that saves provider time. We automatically handle normal and clinically insignificant lab results, and help providers get through abnormal lab results faster. Our AI automatically groups, analyzes, and trends lab results into a smart summary, including possible next steps and a complete patient note. We also route"noise" to staff, reducing the number of messages a physician needs to pay attention to by up to 30%. The result is 5+ hours saved per week per provider. Plus, Affineon tightly integrates with the EHR, so providers don’t need to change their existing workflow.
Winning Mindset Ventures VC Fund · Gräfelfing, Bayern, Germany
Startseite von Winning Mindset Ventures
Show more
Investment focus
  • Medical, Software, Consulting
  • Series A
  • Germany
Portfolio highlights
  • deepc — The Radiology AI Platform - Your effortless access to AI
  • XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
HealthCap VC Fund · Stockholm, Stockholms Lan, Sweden · 5 investments in the past 12 months
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Funding Round
  • United States, Sweden, France
Portfolio highlights
  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
  • Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
TruVenturo VC Fund · Hamburg, Hamburg, Germany
TruVenturo is an entrepreneurial investor and company builder in Europe and the United States
Show more
Investment focus
  • Hospitality, Biotechnology, Travel
  • Seed, Series A, Funding Round
  • Germany, United States, Spain
Portfolio highlights
  • Rune Labs — Software and data platform for neuromodulation
  • get.me — get.me connects social media accounts or links to sites. They create a free link in their bio page that earns money and turns followers into paying subscribers, so they earn money from social media with every subscriber.
  • Tomorrow Bio — At Tomorrow Bio, we use the latest technology to preserve you for however long it takes until medical technology can extend your life.
b2venture VC Fund · Saint Gallen, Sankt Gallen, Switzerland · 9 investments in the past 12 months
B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.
Show more
Investment focus
  • Software, Health Care, Artificial Intelligence
  • Series A, Seed, Series B
  • Germany, Switzerland, United Kingdom
Portfolio highlights
  • Kiin Bio — Accelerate drug discovery with Virtual Scientists. Unified platform integrating 100+ specialized tools into one intelligent workflow.
  • assemblean — assemblean goal is to construct the digital manufacturing infrastructure of the future. We want to make it possible for everyone to build physical items as readily as software.
  • Nautica Technologies — Nautica Technologies is developing intelligent robotic technologies for autonomous ship hull cleaning and inspection. we operate at the convergence of robots, autonomy, and data to solve important difficulties in the marine industry.
Entrée Capital VC Fund · London, England, United Kingdom · 16 investments in the past 12 months
We're a team of former serial founders managing over $1.25B across a number of funds, with offices in Tel Aviv, London, and New York.
Show more
Investment focus
  • Software, Financial Services, FinTech
  • Seed, Series A, Series B
  • United States, Israel, United Kingdom
Portfolio highlights
  • Classiq Technologies — A software platform that helps users create scalable complex quantum computer algorithms, software, and circuits for any gate-based quantum computer
  • Freename — Redefining Web3 Naming System. Web3 Registrar: custom TLDs and Domains
  • Weavy — Weavy is a company focused on enhancing team collaboration by providing developers with pre-built, seamlessly integrated collaboration features for web applications. Their platform offers components such as chat, messaging, file sharing, AI tools, and cloud integrations designed to save developers from repetitive coding tasks, enabling them tobuild smarter and faster without reinventing the wheel. Weavy's tools emphasize developer-friendliness, intuitive user experience, and cost-effectiveness, aiming to empower developers across skill levels to embed collaboration and AI-driven capabilities into internal apps efficiently.
AQAL Integral Investing VC Fund · Munich, Bayern, Germany
Munich-based AQAL Group is an active technology and impact holding company using the Integral Investing approach. Focus: exponential technology and digital evolution (Internet infrastructure, artificial intelligence, blockchain & financial tech, B2B IT solutions, Industry 4.0), green technology (renewable energy, energy efficiency, cleantech, circular economy), and life in the 21st century (future mobility, food, life science, med tech, media & entertainment tech).
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Seed, Pre-Seed
  • Germany, United States
Portfolio highlights
  • DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
  • wondder — Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy, successful, productive teams. Experience the power of wondder. Contact Us Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy,
  • Elona Health — Elona Health creates digital solutions that shape tomorrow's psychotherapy and support patients and therapists alike.
Boehringer Ingelheim Venture Fund VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 3 investments in the past 12 months
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Germany, Belgium
Portfolio highlights
  • Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
  • Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
  • Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
Bertelsmann Investments VC Fund · Gütersloh, Nordrhein-Westfalen, Germany
The Bertelsmann Investments division pools Bertelsmann's holdings in startups around the world.
Show more
Investment focus
  • Health Care, Artificial Intelligence, Medical
  • Series B, Series A, Seed
  • Germany, Israel, Malaysia
Portfolio highlights
  • deepc — The Radiology AI Platform - Your effortless access to AI
  • Doccla — We are a start-up. However, our management and advisors combine 100 years of experience in service delivery to large public and private healthcare operators in six European states, as well as several years in wearable device implementation in the global consumer space.
  • Guardoc Health — Streamlining clinical compliance with AI-driven accuracy in charting to meet regulations, enhance patient care, and optimize revenue management.
ES KAPITAL VC Fund
Kapitalbeteiligungsgesellschaft der Kreissparkasse Esslingen-Nürtingen mbH
Show more
Investment focus
  • Software, EdTech, Medical
  • Seed, Pre-Seed, Series A
  • Germany
Portfolio highlights
  • gyde — Gyde offers digital micro-learning and cross-company coaching for managers.
  • VISPA — Your virtual unlimited space for innovation projects, workshop facilitation, and agile meetings. With more than 30 available pre-built templates.
  • NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.
DocCheck Guano AG VC Fund · Cologne, Nordrhein-Westfalen, Germany
Birds of a feather flock together? Not our style! We promote healthcare startups who believe in their vision and want to be a success at it. DocCheck Guano is a hatchery for precocial birds aiming to land in the market. We provide the ideal fertiliser for startups: capital, know-how, market access and network. Oh, and our focus is on seed funding.
Show more
Investment focus
  • Health Care, Medical Device, Mobile Apps
  • Seed, Funding Round, Pre-Seed
  • Germany, Spain, The Netherlands
Portfolio highlights
  • Amparo — We empower amputees so they can live life to the full. Amparo is a developer, manufacturer and distributor of prosthetic components. It developed the Confidence Socket, which is the interface between the patient's residual limb and the prosthetic leg itself. 1) The fitting process is as fast as 1h time; 2) The material can be remolded 10times, saving huge costs of health providers; and 3) All tools fit into a sports bag. making it possible to service amputee anywhere in the world.
  • medflex — medflex offers secure medical communication via messaging, video calls, and video consultation services.
  • Mammoth Hunters — Mammoth Hunters is a 360° wellness solution offering accessible functional training, natural nutrition and lifestyle advice packaged as a mobile/web based SaaS. The founders come from a scientific background and use discoveries in human physiology and evolution to create personalized fitness journeys. The program is designed toeliminate all barriers that prevent people from leading a healthy lifestyle - lack of time, knowledge and motivation. The company employs 12+ people in Barcelona Spain and has key partnerships with fitness experts, healthcare companies, and sports technology companies.
APEX Ventures VC Fund · Vienna, Wien, Austria · 2 investments in the past 12 months
APEX Ventures is a deep-tech and medical-focused venture capital firm.
Show more
Investment focus
  • Artificial Intelligence, Health Care, Software
  • Seed, Series A, Pre-Seed
  • Germany, United Kingdom, Austria
Portfolio highlights
  • GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
  • HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
  • TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
Wellington Partners VC Fund · Munich, Bayern, Germany · 7 investments in the past 12 months
Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Funding Round
  • Germany, United States, United Kingdom
Portfolio highlights
  • Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
  • Sphingotec GmbH — Improving patient outcomes with innovative diagnostics for critical care: Actionable insights in real-time
  • CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Asabys Partners VC Fund · Barcelona, Catalonia, Spain · 3 investments in the past 12 months
Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.
Show more
Investment focus
  • Biotechnology, Medical Device, Health Care
  • Series A, Seed, Series B
  • Spain, France, Belgium
Portfolio highlights
  • Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
  • DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
  • INBRAIN Neuroelectronics — We are scientists, doctors, techies and humanity lovers, with the mission of building neuroelectronic interfaces to cure brain disorders.
APEX Ventures VC Fund · Vienna, Wien, Austria · 4 investments in the past 12 months
APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.
Show more
Investment focus
  • Artificial Intelligence, Health Care, Software
  • Seed, Series A, Pre-Seed
  • Germany, United Kingdom, Austria
Portfolio highlights
  • Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
  • Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
  • HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
MassMutual Ventures VC Fund · Boston, Massachusetts, United States · 12 investments in the past 12 months
MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.
Show more
Investment focus
  • Software, Financial Services, Information Technology
  • Series A, Series B, Seed
  • United States, India, Singapore
Portfolio highlights
  • DePoly — DePoly is a spin off out of the LSMO lab at EPFL- Valais that has developed a novel technology allowing for the chemical recycling of PET plastic back to its main two components ethylene glycol (EG) and terephthalic acid (TPA). Our approach turns low valued materials (PET waste) into high-valued chemicals like TPA creating a circular economy. Weexpect this process to generate revenue from chemically recycling PET to TPA/EG, which can be sold back to industry to make new virgin PET plastic and allowing for a sustainable source of TPA and EG on the market.
  • CloudSEK — CloudSEK leverages contextual AI to predict and prevent cyber threats. Keep your organisation safe and secure.
  • Griffin — Griffin is making a bank you can build on. They provide banking-as-a-service solutions for companies that want to offer financial services products. The company is currently seeking regulatory approval from the PRA and FCA to become the UK's first platform bank. It was founded in 2017 and based in London, England.
The TQ Group VC Fund · Seefeld, Bayern, Germany
TQ Group is one of the leading technology companies in the electronics industry, offering a complete range of services
Show more
Investment focus
  • Sports, Hardware, Robotics
  • Seed, Series A, Series B
  • Germany
Portfolio highlights
  • enna — enna is the window to the digital world for people who have problems using smartphones or tablets
  • Mellow Boards — Mellow Boards designs and manufactures electric drive system that could fit on skateboards. Unlike all other offers on the market, within minutes Mellow can pimp your favorite board into a high-quality e-board with a top speed of 40km/h ( 25mph).The product was launch in Kickstarter and reached a funding of more than 100 thousand Euros.Founded in 2015, Mellow is based in Hamburg, Germany.
  • Reactive Robotics — Reactive Robotics was founded as a GmbH in Munich, Germany, in April 2015. Their team has a combined 12 years of rehabilitation robotics research, vast startup experience and a large clinical network to bring this device to life. They are proud to feature an excellent array of supporters that provide advice on every level required for thesuccessful start-up of a medical technology company. Confirmed advisors provide access to patients, support them in engineering, on legal issues and when dealing with the details of registering a medical device with the authorities.
American RENOLIT Corporation VC Fund · Swedesboro, New Jersey, United States
With decorative, high-quality and sustainable plastic products, we create clear added value for our customers and improve the quality of life.
Show more
Investment focus
  • Health Care, Medical Device, 3D Printing
  • Series A
  • Germany
Portfolio highlights
  • Kumovis — The EXT 220 MED, formerly the Kumovis R1, is the only extrusion platform that features an integrated clean room and is validated by leading medical device manufacturers and hospitals worldwide.
  • Inovedis — The SINEFIX Implant System is an easy-to-learn solution aimed at simplifying rotator cuff repair procedures and improving patient outcomes.
Grönemeyer Health VC Fund · Bochum, Nordrhein-Westfalen, Germany
Grönemeyer Health is a venture capital investment firm.
Show more
Investment focus
  • Medical, Manufacturing, Medical Device
  • Series A
  • Germany
Portfolio highlights
  • Atlas Medical Technologies — Atlas Medical Technologies is a manufacturing company that develops navigation systems for medical doctors for radiology and orthopedics.
Norgine Ventures VC Fund · Uxbridge, Hillingdon, United Kingdom
Norgine Ventures was started in 2012 to diversify Norgine’s activities and foster innovation in the healthcare sector. Norgine Ventures provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences, in Europe and the US. Norgine Ventures is backed by Norgine, a fully integrated, private,European healthcare company with over 110 years of experience in the pharma space.Norgine Ventures has full access to Norgine’s technical capabilities for evaluating investment opportunities, although the business is aimed at achieving a financial return rather than funding opportunities of strategic interest to Norgine.To date, Norgine Ventures has invested in a number of businesses, including specialty pharma, diagnostic and medical device companies, at various stages of their life cycle, both in Europe and in the US.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Funding Round, Debt Financing, Series A
  • France, United Kingdom, United States
Portfolio highlights
  • ImaginAb — ImaginAb is a pioneering biotech company, innovating for tomorrow with modern radiopharmaceutical advances. Our advanced imaging solutions like CD8 ImmunoPET are aimed to accelerate the progress of physicians all over the world, ending the need for repeat, painful biopsies.
  • PathoQuest — PathoQuest provides a pioneering next generation sequencing (NGS) approach to biologics characterization and release testing
  • Impress — Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020.
Investors by industry
Investors by country
VC (Venture Capital) Funds in Germany by industry